Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pleural Effusion, Malignant × Verteporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Glioblastoma 2 Breast Neoplasms 2 Pleural Effusion, Malignant 1 Pinealoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Neuroepithelial 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Medulloblastoma 1 Malignant Solid Neoplasm 1 Gliosarcoma 1 Glioma, Subependymal 1 Familial ependymoma 1 Ependymoma 1 Craniopharyngioma 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Cisplatin 8 Carboplatin 7 Bevacizumab 7 Talc 6 Pleurodesis 5 Paclitaxel 5 Doxycycline 4 Docetaxel 4 Taxes 3 Gemcitabine 3 Zoledronic Acid 2 Trastuzumab 2 Thoracoscopy 2 Sodium Chloride 2 Silver Nitrate 2 Povidone-Iodine 2 Nivolumab 2 Fluorodeoxyglucose F18 2 Fentanyl 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Chest Tubes 2 Bortezomib 2 viscum album peptide 1 tocilizumab 1 tipifarnib 1 talimogene laherparepvec 1 romidepsin 1 rilotumumab 1 lipoplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02702700 2019-03-20

PDT-lipo

Centre Hospitalier Universitaire Vaudois

Phase 1 Terminated

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡